Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications
- 23 October 2023
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (11) , 5278-5311
Abstract
Recently, stem cells and their secretomes have attracted great attention in biomedical applications, particularly extracellular vesicles (EVs). EVs are secretomes of cells for cell-to-cell communication. They play a role as intercellular messengers as they carry proteins, nucleic acids, lipids, and therapeutic agents. They have also been utilized as drug-delivery vehicles due to their biocompatibility, low immunogenicity, stability, targetability, and engineerable properties. The therapeutic potential of EVs can be further enhanced by surface engineering and modification using functional molecules such as aptamers, peptides, and antibodies. As a consequence, EVs hold great promise as effective delivery vehicles for enhancing treatment efficacy while avoiding side effects. Among various cell types that secrete EVs, stem cells are ideal sources of EVs because stem cells have unique properties such as self-renewal and regenerative potential for transplantation into damaged tissues that can facilitate their regeneration. However, challenges such as immune rejection and ethical considerations remain significant hurdles. Stem cell-derived EVs have been extensively explored as a cell-free approach that bypasses many challenges associated with cell-based therapy in cancer therapy and tissue regeneration. In this review, we summarize and discuss the current knowledge of various types of stem cells as a source of EVs, their engineering, and applications of EVs, focusing on cancer therapy and tissue engineering.Keywords
Funding Information
- National Research Foundation of Korea (2021R1G1A1095778)
- Soonchunhyang University
This publication has 253 references indexed in Scilit:
- Adipose tissue-derived stem cells in clinical applicationsExpert Opinion on Biological Therapy, 2013
- Nucleic acids in exosomes: Disease markers and intercellular communication moleculesBiochemistry (Moscow), 2013
- Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic ProteasomeInternational Journal of Proteomics, 2012
- Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytesNucleic Acids Research, 2012
- Multipotent mesenchymal stromal cells and the innate immune systemNature Reviews Immunology, 2012
- Exosome mimetics: a novel class of drug delivery systemsInternational Journal of Nanomedicine, 2012
- Risk factors in the development of stem cell therapyJournal of Translational Medicine, 2011
- Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendagesCell and tissue research, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's DiseaseStem Cells, 2005